TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP2858	Ectoderm Differentiation	0.0531403341295401	-2.93481905094837	143	1	0.5	2	5310	2720	GLB1
WP3594	Circadian rythm related genes	0.076453480018846	-2.57107282744889	207	1	0.5	2	5310	4669	NAGLU
WP531	Mismatch repair	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP561	Heme Biosynthesis	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP3300	Dual hijack model of Vif in HIV infection	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP3674	Tgif disruption of Shh signaling	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP696	Benzo(a)pyrene metabolism	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP3297	EV release from cardiac cells and their functional effects	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP3875	ATR Signaling	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP3585	Cytosine methylation	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP288	NLR Proteins	0.999999999989981	-1.00192105652182e-11	9	0	0	2	5310
WP1434	Osteopontin Signaling	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP3871	Valproic acid pathway	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP2881	Estrogen Receptor Pathway	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP186	Homologous recombination	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP3892	Development of pulmonary dendritic cells and macrophage subsets	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP1423	Ganglio Sphingolipid Metabolism	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	0.999999999990797	-9.20333446157904e-12	13	0	0	2	5310
WP455	GPCRs, Class A Rhodopsin-like	0.999999999992662	-7.33794101870355e-12	259	0	0	2	5310
WP2029	Cell Differentiation - Index	0.999999999993798	-6.20192649135581e-12	38	0	0	2	5310
WP2526	PDGF Pathway	0.999999999993798	-6.20192649135581e-12	38	0	0	2	5310
WP2447	Amyotrophic lateral sclerosis (ALS)	0.999999999993798	-6.20192649135581e-12	38	0	0	2	5310
WP383	Striated Muscle Contraction	0.999999999993798	-6.20192649135581e-12	38	0	0	2	5310
WP254	Apoptosis	0.999999999995003	-4.99681177511258e-12	86	0	0	2	5310
WP428	Wnt Signaling Pathway	0.999999999997023	-2.97734571914378e-12	70	0	0	2	5310
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.999999999997023	-2.97734571914378e-12	70	0	0	2	5310
WP3287	Overview of nanoparticle effects	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP247	Small Ligand GPCRs	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP22	IL-9 Signaling Pathway	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP1992	TarBasePathway	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP384	Apoptosis Modulation by HSP70	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP404	Nucleotide Metabolism	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP697	Estrogen metabolism	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP2879	Farnesoid X Receptor  Pathway	0.999999999997225	-2.77477127612455e-12	19	0	0	2	5310
WP195	IL-1 signaling pathway	0.999999999997232	-2.76829287845868e-12	57	0	0	2	5310
WP2795	Cardiac Hypertrophic Response	0.999999999997232	-2.76829287845868e-12	57	0	0	2	5310
WP236	Adipogenesis	0.999999999998002	-1.99808572465265e-12	131	0	0	2	5310
WP2338	miRNA Biogenesis	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP1604	Codeine and Morphine Metabolism	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP3655	Hypothetical Craniofacial Development Pathway	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP2276	Glial Cell Differentiation	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP2485	NAD Biosynthesis II (from tryptophan)	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP136	Phase I biotransformations, non P450	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP3407	FTO Obesity Variant Mechanism	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP3635	Insulin signalling in human adipocytes (diabetic condition)	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP3634	Insulin signalling in human adipocytes (normal condition)	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP1589	Folate-Alcohol and Cancer Pathway	0.99999999999816	-1.83963271667152e-12	8	0	0	2	5310
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	0.999999999998271	-1.7286279964954e-12	47	0	0	2	5310
WP2377	Integrated Pancreatic Cancer Pathway	0.999999999998312	-1.68824394568279e-12	197	0	0	2	5310
WP2857	Mesodermal Commitment Pathway	0.999999999998319	-1.68065745782126e-12	155	0	0	2	5310
WP23	B Cell Receptor Signaling Pathway	0.999999999998839	-1.16053564327978e-12	98	0	0	2	5310
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	0.999999999998849	-1.15144840351225e-12	5	0	0	2	5310
WP311	Synthesis and Degradation of Ketone Bodies	0.999999999998849	-1.15144840351225e-12	5	0	0	2	5310
WP3596	miR-517 relationship with ARCN1 and USP1	0.999999999998849	-1.15144840351225e-12	5	0	0	2	5310
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	0.999999999998849	-1.15144840351225e-12	5	0	0	2	5310
WP2542	Sulindac Metabolic Pathway	0.999999999998849	-1.15144840351225e-12	5	0	0	2	5310
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	0.999999999998849	-1.15144840351225e-12	5	0	0	2	5310
WP2267	Synaptic Vesicle Pathway	0.999999999998911	-1.08935424699905e-12	52	0	0	2	5310
WP382	MAPK Signaling Pathway	0.999999999999119	-8.81321708320892e-13	170	0	0	2	5310
WP710	DNA Damage Response (only ATM dependent)	0.999999999999334	-6.66257142772214e-13	114	0	0	2	5310
WP2371	Parkinsons Disease Pathway	0.999999999999742	-2.57628011805788e-13	83	0	0	2	5310
WP2261	Signaling Pathways in Glioblastoma	0.999999999999742	-2.57628011805788e-13	83	0	0	2	5310
WP2324	AGE/RAGE pathway	0.999999999999881	-1.18979099576061e-13	66	0	0	2	5310
WP2374	Oncostatin M Signaling Pathway	0.999999999999881	-1.18979099576061e-13	66	0	0	2	5310
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	0.999999999999881	-1.18979099576061e-13	66	0	0	2	5310
WP183	Proteasome Degradation	0.999999999999881	-1.18979099576061e-13	66	0	0	2	5310
WP3527	Preimplantation Embryo	0.999999999999942	-5.77884907895093e-14	60	0	0	2	5310
WP558	Complement and Coagulation Cascades	0.999999999999942	-5.77884907895093e-14	60	0	0	2	5310
WP304	Kit receptor signaling pathway	0.999999999999942	-5.77884907895093e-14	60	0	0	2	5310
WP716	Vitamin A and Carotenoid Metabolism	0.999999999999965	-3.49193466026368e-14	44	0	0	2	5310
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	0.999999999999965	-3.49193466026368e-14	44	0	0	2	5310
WP2332	Interleukin-11 Signaling Pathway	0.999999999999965	-3.49193466026368e-14	44	0	0	2	5310
WP2059	Alzheimers Disease	1.00000000000024	2.41530428470027e-13	148	0	0	2	5310
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	1.00000000000063	6.27741517892234e-13	35	0	0	2	5310
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1.00000000000063	6.27741517892234e-13	35	0	0	2	5310
WP244	Alpha 6 Beta 4 signaling pathway	1.00000000000063	6.27741517892234e-13	35	0	0	2	5310
WP2249	Metastatic brain tumor	1.00000000000063	6.29991982789135e-13	28	0	0	2	5310
WP2361	Gastric Cancer Network 1	1.00000000000063	6.29991982789135e-13	28	0	0	2	5310
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	1.00000000000086	8.58910785241562e-13	27	0	0	2	5310
WP3845	Canonical  and Non-canonical Notch signaling	1.00000000000086	8.58910785241562e-13	27	0	0	2	5310
WP289	Myometrial Relaxation and Contraction Pathways	1.00000000000105	1.04717319884817e-12	158	0	0	2	5310
WP707	DNA Damage Response	1.00000000000114	1.13613954941076e-12	69	0	0	2	5310
WP176	Folate Metabolism	1.00000000000114	1.13613954941076e-12	69	0	0	2	5310
WP2369	Histone Modifications	1.00000000000114	1.13613954941076e-12	69	0	0	2	5310
WP897	Androgen receptor signaling pathway	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP1133	Androgen receptor signaling pathway	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP2253	Pilocytic astrocytoma	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP690	Polyol Pathway	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP521	Amino acid conjugation of benzoic acid	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP2889	Oxytocin signaling	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP3633	Caffeine and Theobromine metabolism	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP2491	Diclofenac Metabolic Pathway	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP733	Serotonin Receptor 2 and STAT3 Signaling	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP1603	Nicotine Activity on Chromaffin Cells	1.00000000000116	1.16182797256471e-12	4	0	0	2	5310
WP179	Cell Cycle	1.0000000000012	1.204254469582e-12	105	0	0	2	5310
WP477	Cytoplasmic Ribosomal Proteins	1.00000000000169	1.68512241920799e-12	90	0	0	2	5310
WP138	Androgen receptor signaling pathway	1.00000000000169	1.68512241920799e-12	90	0	0	2	5310
WP3601	Composition of Lipid Particles	1.00000000000185	1.84802666748914e-12	10	0	0	2	5310
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	1.00000000000185	1.84802666748914e-12	10	0	0	2	5310
WP2113	Type III interferon signaling	1.00000000000185	1.84802666748914e-12	10	0	0	2	5310
WP1531	Vitamin D Metabolism	1.00000000000185	1.84802666748914e-12	10	0	0	2	5310
WP496	Steroid Biosynthesis	1.00000000000185	1.84802666748914e-12	10	0	0	2	5310
WP704	Methylation Pathways	1.00000000000185	1.84802666748914e-12	10	0	0	2	5310
WP2333	Trans-sulfuration pathway	1.00000000000185	1.84802666748914e-12	10	0	0	2	5310
WP2874	Liver X Receptor Pathway	1.00000000000185	1.84802666748914e-12	10	0	0	2	5310
WP2431	Spinal Cord Injury	1.00000000000191	1.91311083728302e-12	119	0	0	2	5310
WP51	Regulation of Actin Cytoskeleton	1.0000000000021	2.09774613044861e-12	149	0	0	2	5310
WP2037	Prolactin Signaling Pathway	1.0000000000021	2.10184129757936e-12	76	0	0	2	5310
WP2034	Leptin signaling pathway	1.0000000000021	2.10184129757936e-12	76	0	0	2	5310
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	1.0000000000021	2.10184129757936e-12	76	0	0	2	5310
WP2884	NRF2 pathway	1.00000000000213	2.12762034552949e-12	143	0	0	2	5310
WP2643	Nanoparticle-mediated activation of receptor signaling	1.00000000000236	2.364778806666e-12	29	0	0	2	5310
WP3613	Photodynamic therapy-induced unfolded protein response	1.00000000000236	2.364778806666e-12	29	0	0	2	5310
WP422	MAPK Cascade	1.00000000000236	2.364778806666e-12	29	0	0	2	5310
WP2583	T-Cell Receptor and Co-stimulatory Signaling	1.00000000000236	2.364778806666e-12	29	0	0	2	5310
WP702	Metapathway biotransformation	1.00000000000266	2.65813933364445e-12	177	0	0	2	5310
WP1422	Sphingolipid Metabolism	1.00000000000272	2.71880769071484e-12	20	0	0	2	5310
WP516	Hypertrophy Model	1.00000000000272	2.71880769071484e-12	20	0	0	2	5310
WP391	Mitochondrial Gene Expression	1.00000000000272	2.71880769071484e-12	20	0	0	2	5310
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	1.00000000000272	2.71880769071484e-12	20	0	0	2	5310
WP497	Urea cycle and metabolism of amino groups	1.00000000000272	2.71880769071484e-12	20	0	0	2	5310
WP1742	TP53 Network	1.00000000000272	2.71880769071484e-12	20	0	0	2	5310
WP322	Osteoblast Signaling	1.0000000000029	2.90026538043639e-12	14	0	0	2	5310
WP229	Irinotecan Pathway	1.0000000000029	2.90026538043639e-12	14	0	0	2	5310
WP3853	ERK Pathway in Huntington's Disease	1.0000000000029	2.90026538043639e-12	14	0	0	2	5310
WP2436	Dopamine metabolism	1.0000000000029	2.90026538043639e-12	14	0	0	2	5310
WP111	Electron Transport Chain	1.00000000000375	3.74870138186364e-12	92	0	0	2	5310
WP3925	Amino Acid metabolism	1.00000000000404	4.0446911770374e-12	91	0	0	2	5310
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	1.00000000000404	4.0446911770374e-12	91	0	0	2	5310
WP43	Oxidation by Cytochrome P450	1.0000000000041	4.10394594284498e-12	63	0	0	2	5310
WP3624	Lung fibrosis	1.0000000000041	4.10394594284498e-12	63	0	0	2	5310
WP560	TGF-beta Receptor Signaling	1.00000000000431	4.31020616333683e-12	58	0	0	2	5310
WP712	Estrogen signaling pathway	1.00000000000434	4.34204173402905e-12	23	0	0	2	5310
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	1.00000000000434	4.34204173402905e-12	23	0	0	2	5310
WP241	One Carbon Metabolism	1.00000000000437	4.37185496273773e-12	30	0	0	2	5310
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	1.00000000000437	4.37185496273773e-12	30	0	0	2	5310
WP2855	Dopaminergic Neurogenesis	1.00000000000437	4.37185496273773e-12	30	0	0	2	5310
WP98	Prostaglandin Synthesis and Regulation	1.00000000000437	4.37185496273773e-12	30	0	0	2	5310
WP3851	TLR4 Signaling and Tolerance	1.00000000000437	4.37185496273773e-12	30	0	0	2	5310
WP2870	Extracellular vesicle-mediated signaling in recipient cells	1.00000000000437	4.37185496273773e-12	30	0	0	2	5310
WP129	Matrix Metalloproteinases	1.00000000000437	4.37185496273773e-12	30	0	0	2	5310
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1.00000000000455	4.54520112953133e-12	31	0	0	2	5310
WP408	Oxidative Stress	1.00000000000455	4.54520112953133e-12	31	0	0	2	5310
WP2112	IL17 signaling pathway	1.00000000000455	4.54520112953133e-12	31	0	0	2	5310
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	1.00000000000459	4.59478243349182e-12	12	0	0	2	5310
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1.00000000000459	4.59478243349182e-12	12	0	0	2	5310
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	1.00000000000459	4.59478243349182e-12	12	0	0	2	5310
WP2290	RalA downstream regulated genes	1.00000000000459	4.59478243349182e-12	12	0	0	2	5310
WP106	Alanine and aspartate metabolism	1.00000000000459	4.59478243349182e-12	12	0	0	2	5310
WP2007	Iron metabolism in placenta	1.00000000000459	4.59478243349182e-12	12	0	0	2	5310
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	1.00000000000459	4.59478243349182e-12	12	0	0	2	5310
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	1.00000000000459	4.59478243349182e-12	12	0	0	2	5310
WP1545	miRNAs involved in DNA damage response	1.00000000000479	4.79445216167163e-12	50	0	0	2	5310
WP2637	Structural Pathway of Interleukin 1 (IL-1)	1.00000000000479	4.79445216167163e-12	50	0	0	2	5310
WP691	Tamoxifen metabolism	1.00000000000484	4.84003850758123e-12	21	0	0	2	5310
WP2507	Nanomaterial induced apoptosis	1.00000000000484	4.84003850758123e-12	21	0	0	2	5310
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	1.00000000000484	4.84003850758123e-12	21	0	0	2	5310
WP2533	Glycerophospholipid Biosynthetic Pathway	1.00000000000484	4.84003850758123e-12	21	0	0	2	5310
WP1602	Nicotine Activity on Dopaminergic Neurons	1.00000000000484	4.84003850758123e-12	21	0	0	2	5310
WP334	GPCRs, Class B Secretin-like	1.00000000000484	4.84195586999536e-12	24	0	0	2	5310
WP1539	Angiogenesis	1.00000000000484	4.84195586999536e-12	24	0	0	2	5310
WP262	EBV LMP1 signaling	1.00000000000484	4.84195586999536e-12	24	0	0	2	5310
WP2509	Nanoparticle triggered autophagic cell death	1.00000000000484	4.84195586999536e-12	24	0	0	2	5310
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	1.00000000000484	4.84195586999536e-12	24	0	0	2	5310
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	1.00000000000488	4.87810190326473e-12	41	0	0	2	5310
WP2328	Allograft Rejection	1.00000000000493	4.9313165584406e-12	80	0	0	2	5310
WP411	mRNA Processing	1.0000000000051	5.10062337418654e-12	132	0	0	2	5310
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	1.0000000000051	5.10062337418654e-12	132	0	0	2	5310
WP481	Insulin Signaling	1.00000000000514	5.14459232592995e-12	161	0	0	2	5310
WP2878	PPAR Alpha Pathway	1.00000000000525	5.24954103624242e-12	26	0	0	2	5310
WP698	Glucuronidation	1.00000000000525	5.24954103624242e-12	26	0	0	2	5310
WP26	Signal Transduction of S1P Receptor	1.00000000000525	5.24954103624242e-12	26	0	0	2	5310
WP325	Triacylglyceride Synthesis	1.00000000000525	5.24954103624242e-12	26	0	0	2	5310
WP581	EPO Receptor Signaling	1.00000000000525	5.24954103624242e-12	26	0	0	2	5310
WP530	Cytokines and Inflammatory Response	1.00000000000525	5.24954103624242e-12	26	0	0	2	5310
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	1.00000000000534	5.33645236290223e-12	73	0	0	2	5310
WP2406	Cardiac Progenitor Differentiation	1.00000000000537	5.37278584795096e-12	53	0	0	2	5310
WP1533	Vitamin B12 Metabolism	1.00000000000537	5.37278584795096e-12	53	0	0	2	5310
WP107	Translation Factors	1.00000000000537	5.37278584795096e-12	53	0	0	2	5310
WP363	Wnt Signaling Pathway Netpath	1.00000000000537	5.37278584795096e-12	53	0	0	2	5310
WP24	Peptide GPCRs	1.00000000000564	5.63633886199906e-12	74	0	0	2	5310
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	1.00000000000564	5.63633886199906e-12	74	0	0	2	5310
WP306	Focal Adhesion	1.00000000000566	5.65849580733135e-12	195	0	0	2	5310
WP3408	Evolocumab Mechanism	1.0000000000059	5.90484469781244e-12	3	0	0	2	5310
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	1.0000000000059	5.90484469781244e-12	3	0	0	2	5310
WP1772	Apoptosis Modulation and Signaling	1.00000000000612	6.12034462823749e-12	94	0	0	2	5310
WP231	TNF alpha Signaling Pathway	1.00000000000612	6.12034462823749e-12	94	0	0	2	5310
WP1984	Integrated Breast Cancer Pathway	1.00000000000614	6.14363085144759e-12	154	0	0	2	5310
WP534	Glycolysis and Gluconeogenesis	1.0000000000063	6.30310617610354e-12	49	0	0	2	5310
WP286	IL-3 Signaling Pathway	1.0000000000063	6.30310617610354e-12	49	0	0	2	5310
WP410	Diurnally Regulated Genes with Circadian Orthologs	1.0000000000063	6.30310617610354e-12	49	0	0	2	5310
WP3286	Copper homeostasis	1.00000000000633	6.3336624492186e-12	54	0	0	2	5310
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1.00000000000633	6.3336624492186e-12	54	0	0	2	5310
WP623	Oxidative phosphorylation	1.00000000000633	6.3336624492186e-12	54	0	0	2	5310
WP673	ErbB Signaling Pathway	1.00000000000633	6.3336624492186e-12	54	0	0	2	5310
WP430	Statin Pathway	1.00000000000653	6.526217988332e-12	33	0	0	2	5310
WP3676	BDNF-TrkB Signaling	1.00000000000653	6.526217988332e-12	33	0	0	2	5310
WP453	Inflammatory Response Pathway	1.00000000000653	6.526217988332e-12	33	0	0	2	5310
WP2197	Endothelin Pathways	1.00000000000653	6.526217988332e-12	33	0	0	2	5310
WP58	Monoamine GPCRs	1.00000000000653	6.526217988332e-12	33	0	0	2	5310
WP2363	Gastric Cancer Network 2	1.00000000000653	6.526217988332e-12	33	0	0	2	5310
WP2853	Endoderm Differentiation	1.0000000000067	6.69950347368525e-12	145	0	0	2	5310
WP1449	Regulation of toll-like receptor signaling pathway	1.0000000000067	6.69950347368525e-12	145	0	0	2	5310
WP2355	Corticotropin-releasing hormone signaling pathway	1.00000000000682	6.81795619310657e-12	93	0	0	2	5310
WP1530	miRNA Regulation of DNA Damage Response	1.00000000000682	6.81795619310657e-12	93	0	0	2	5310
WP474	Endochondral Ossification	1.00000000000683	6.83256795868011e-12	65	0	0	2	5310
WP2012	miRs in Muscle Cell Differentiation	1.00000000000685	6.84789163850515e-12	36	0	0	2	5310
WP3298	Melatonin metabolism and effects	1.00000000000685	6.84789163850515e-12	36	0	0	2	5310
WP500	Glycogen Metabolism	1.00000000000685	6.84789163850515e-12	36	0	0	2	5310
WP170	Nuclear Receptors	1.00000000000689	6.89239504093322e-12	39	0	0	2	5310
WP3878	ATM Signaling Network in Development and Disease	1.00000000000696	6.95696558900612e-12	46	0	0	2	5310
WP1591	Heart Development	1.00000000000696	6.95696558900612e-12	46	0	0	2	5310
WP1971	Integrated Cancer Pathway	1.00000000000696	6.95696558900612e-12	46	0	0	2	5310
WP465	Tryptophan metabolism	1.00000000000696	6.95696558900612e-12	46	0	0	2	5310
WP28	Selenium Metabolism and Selenoproteins	1.00000000000696	6.95696558900612e-12	46	0	0	2	5310
WP268	Notch Signaling Pathway	1.00000000000696	6.95696558900612e-12	46	0	0	2	5310
WP117	GPCRs, Other	1.00000000000709	7.08569233018666e-12	95	0	0	2	5310
WP35	G Protein Signaling Pathways	1.00000000000709	7.08569233018666e-12	95	0	0	2	5310
WP3865	RIG-I-like Receptor Signaling	1.00000000000714	7.13525923458705e-12	61	0	0	2	5310
WP585	Interferon type I signaling pathways	1.00000000000734	7.33705063122193e-12	55	0	0	2	5310
WP2272	Pathogenic Escherichia coli infection	1.00000000000734	7.33705063122193e-12	55	0	0	2	5310
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	1.00000000000734	7.33705063122193e-12	55	0	0	2	5310
WP395	IL-4 Signaling Pathway	1.00000000000734	7.33705063122193e-12	55	0	0	2	5310
WP49	IL-2 Signaling Pathway	1.00000000000797	7.96862237111527e-12	42	0	0	2	5310
WP405	Eukaryotic Transcription Initiation	1.00000000000797	7.96862237111527e-12	42	0	0	2	5310
WP466	DNA Replication	1.00000000000797	7.96862237111527e-12	42	0	0	2	5310
WP2636	Common Pathways Underlying Drug Addiction	1.00000000000797	7.96862237111527e-12	42	0	0	2	5310
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	1.00000000000797	7.96862237111527e-12	42	0	0	2	5310
WP1471	Target Of Rapamycin (TOR) Signaling	1.00000000000801	8.006082233801e-12	37	0	0	2	5310
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	1.00000000000801	8.006082233801e-12	37	0	0	2	5310
WP619	Type II interferon signaling (IFNG)	1.00000000000801	8.006082233801e-12	37	0	0	2	5310
WP3529	Zinc homeostasis	1.00000000000801	8.006082233801e-12	37	0	0	2	5310
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1.00000000000801	8.006082233801e-12	37	0	0	2	5310
WP2848	Differentiation Pathway	1.00000000000803	8.03296066275404e-12	48	0	0	2	5310
WP2849	Hematopoietic Stem Cell Differentiation	1.00000000000803	8.03296066275404e-12	48	0	0	2	5310
WP2586	Aryl Hydrocarbon Receptor	1.00000000000803	8.03296066275404e-12	48	0	0	2	5310
WP2873	Aryl Hydrocarbon Receptor Pathway	1.00000000000803	8.03296066275404e-12	48	0	0	2	5310
WP1273	Folic Acid Network	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP2816	Felbamate Metabolism	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP1438	Influenza A virus infection	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP2866	mir34a and TGIF2 in osteoclastogenesis	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP2943	Hypoxia-mediated EMT and Stemness	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP2646	Lidocaine metabolism	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP1311	Folic Acid Network	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP2366	Butyrate-induced histone acetylation	1.00000000000815	8.15168021947072e-12	2	0	0	2	5310
WP2828	Bladder Cancer	1.00000000000823	8.23478046548583e-12	32	0	0	2	5310
WP727	Monoamine Transport	1.00000000000823	8.23478046548583e-12	32	0	0	2	5310
WP2525	Trans-sulfuration and one carbon metabolism	1.00000000000823	8.23478046548583e-12	32	0	0	2	5310
WP34	Ovarian Infertility Genes	1.00000000000823	8.23478046548583e-12	32	0	0	2	5310
WP2875	Constitutive Androstane Receptor Pathway	1.00000000000823	8.23478046548583e-12	32	0	0	2	5310
WP3858	Toll-like Receptor Signaling	1.00000000000823	8.23478046548583e-12	32	0	0	2	5310
WP3893	Development and heterogeneity of the ILC family	1.00000000000823	8.23478046548583e-12	32	0	0	2	5310
WP545	Complement Activation	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP1584	Type II diabetes mellitus	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP167	Eicosanoid Synthesis	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP3645	NAD+ biosynthetic pathways	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP272	Blood Clotting Cascade	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP3599	Transcription factor regulation in adipogenesis	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP1424	Globo Sphingolipid Metabolism	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP357	Fatty Acid Biosynthesis	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP100	Glutathione metabolism	1.00000000000837	8.37474819785004e-12	22	0	0	2	5310
WP524	G13 Signaling Pathway	1.0000000000086	8.60323624677934e-12	40	0	0	2	5310
WP127	IL-5 Signaling Pathway	1.0000000000086	8.60323624677934e-12	40	0	0	2	5310
WP2516	ATM Signaling Pathway	1.0000000000086	8.60323624677934e-12	40	0	0	2	5310
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	1.00000000000863	8.63039208241073e-12	144	0	0	2	5310
WP550	Biogenic Amine Synthesis	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP3644	NAD+ metabolism	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP47	Hedgehog Signaling Pathway	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP12	Osteoclast Signaling	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP53	ID signaling pathway	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP1946	Cori Cycle	1.00000000000866	8.66171468656197e-12	16	0	0	2	5310
WP437	EGF/EGFR Signaling Pathway	1.00000000000933	9.32547019206337e-12	162	0	0	2	5310
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	1.00000000000933	9.32547019206337e-12	162	0	0	2	5310
WP364	IL-6 signaling pathway	1.00000000000954	9.53514330481135e-12	43	0	0	2	5310
WP2911	miRNA targets in ECM and membrane receptors	1.00000000000954	9.53514330481135e-12	43	0	0	2	5310
WP197	Cholesterol Biosynthesis	1.00000000000959	9.58800126678983e-12	15	0	0	2	5310
WP3	Transcriptional activation by NRF2	1.00000000000959	9.58800126678983e-12	15	0	0	2	5310
WP206	Fatty Acid Omega Oxidation	1.00000000000959	9.58800126678983e-12	15	0	0	2	5310
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000000959	9.58800126678983e-12	15	0	0	2	5310
WP2064	Neural Crest Differentiation	1.00000000001021	1.02119508053715e-11	102	0	0	2	5310
WP1544	MicroRNAs in cardiomyocyte hypertrophy	1.00000000001021	1.02119508053715e-11	102	0	0	2	5310
WP108	Selenium metabolism/Selenoproteins	1.00000000001025	1.02549113948844e-11	1	0	0	2	5310
WP3627	Gut-Liver Indole Metabolism	1.00000000001025	1.02549113948844e-11	1	0	0	2	5310
WP2190	One carbon donor	1.00000000001025	1.02549113948844e-11	1	0	0	2	5310
WP3191	TSLP Signaling Pathway	1.00000000001025	1.02549113948844e-11	1	0	0	2	5310
WP2536	Colchicine Metabolic Pathway	1.00000000001025	1.02549113948844e-11	1	0	0	2	5310
WP188	Focal Adhesion	1.00000000001025	1.02549113948844e-11	1	0	0	2	5310
WP661	Glucose Homeostasis	1.00000000001025	1.02549113948844e-11	1	0	0	2	5310
WP1	Statin Pathway	1.00000000001025	1.02549113948844e-11	1	0	0	2	5310
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	1.00000000001052	1.05205348827162e-11	51	0	0	2	5310
WP3646	Hepatitis C and Hepatocellular Carcinoma	1.00000000001052	1.05205348827162e-11	51	0	0	2	5310
WP75	Toll-like Receptor Signaling Pathway	1.00000000001092	1.09226926548606e-11	103	0	0	2	5310
WP185	Integrin-mediated Cell Adhesion	1.00000000001092	1.09226926548606e-11	103	0	0	2	5310
WP3584	MECP2 and Associated Rett Syndrome	1.0000000000114	1.13956519188444e-11	62	0	0	2	5310
WP61	Notch Signaling Pathway	1.0000000000114	1.13956519188444e-11	62	0	0	2	5310
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	1.0000000000114	1.13956519188444e-11	62	0	0	2	5310
WP615	Senescence and Autophagy in Cancer	1.00000000001154	1.15378034275075e-11	106	0	0	2	5310
WP399	Wnt Signaling Pathway and Pluripotency	1.00000000001154	1.15378034275075e-11	106	0	0	2	5310
WP1601	Fluoropyrimidine Activity	1.00000000001172	1.1721215367928e-11	34	0	0	2	5310
WP313	Signaling of Hepatocyte Growth Factor Receptor	1.00000000001172	1.1721215367928e-11	34	0	0	2	5310
WP400	p38 MAPK Signaling Pathway	1.00000000001172	1.1721215367928e-11	34	0	0	2	5310
WP143	Fatty Acid Beta Oxidation	1.00000000001172	1.1721215367928e-11	34	0	0	2	5310
WP3413	NOTCH1 regulation of human endothelial cell calcification	1.00000000001189	1.18915139948807e-11	18	0	0	2	5310
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	1.00000000001189	1.18915139948807e-11	18	0	0	2	5310
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	1.00000000001189	1.18915139948807e-11	18	0	0	2	5310
WP692	Sulfation Biotransformation Reaction	1.00000000001189	1.18915139948807e-11	18	0	0	2	5310
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	1.00000000001189	1.18915139948807e-11	18	0	0	2	5310
WP15	Selenium Micronutrient Network	1.00000000001195	1.19479258301261e-11	87	0	0	2	5310
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	1.0000000000125	1.24975539018599e-11	17	0	0	2	5310
WP3874	Canonical and Non-Canonical TGF-B signaling	1.0000000000125	1.24975539018599e-11	17	0	0	2	5310
WP78	TCA Cycle	1.0000000000125	1.24975539018599e-11	17	0	0	2	5310
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	1.0000000000125	1.24975539018599e-11	17	0	0	2	5310
WP2289	Drug Induction of Bile Acid Pathway	1.0000000000125	1.24975539018599e-11	17	0	0	2	5310
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	1.0000000000125	1.24975539018599e-11	17	0	0	2	5310
WP554	ACE Inhibitor Pathway	1.0000000000125	1.24975539018599e-11	17	0	0	2	5310
WP528	Acetylcholine Synthesis	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP134	Pentose Phosphate Pathway	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP3924	Hfe effect on hepcidin production	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP1310	Selenium Micronutrient Network	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP699	Aflatoxin B1 metabolism	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP3595	mir-124 predicted interactions with cell cycle and differentiation	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP438	Non-homologous end joining	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP2596	Gastric acid production	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP2805	RNA interference	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP1995	Effects of Nitric Oxide	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP1272	Selenium Micronutrient Network	1.00000000001418	1.41813978624769e-11	7	0	0	2	5310
WP366	TGF-beta Signaling Pathway	1.00000000001428	1.42848063022435e-11	133	0	0	2	5310
WP2446	Retinoblastoma (RB) in Cancer	1.00000000001543	1.54308827000904e-11	88	0	0	2	5310
WP205	IL-7 Signaling Pathway	1.00000000001555	1.55530329792126e-11	25	0	0	2	5310
WP1528	Physiological and Pathological Hypertrophy  of the Heart	1.00000000001555	1.55530329792126e-11	25	0	0	2	5310
WP2865	IL1 and megakaryocytes in obesity	1.00000000001555	1.55530329792126e-11	25	0	0	2	5310
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	1.00000000001555	1.55530329792126e-11	25	0	0	2	5310
WP2895	Differentiation of white and brown adipocyte	1.00000000001555	1.55530329792126e-11	25	0	0	2	5310
WP1600	Nicotine Metabolism	1.00000000001848	1.84808185208799e-11	6	0	0	2	5310
WP1981	Thyroxine (Thyroid Hormone) Production	1.00000000001848	1.84808185208799e-11	6	0	0	2	5310
WP694	Arylamine metabolism	1.00000000001848	1.84808185208799e-11	6	0	0	2	5310
WP3891	Benzene metabolism	1.00000000001848	1.84808185208799e-11	6	0	0	2	5310
WP536	Calcium Regulation in the Cardiac Cell	1.00000000001966	1.96555841264559e-11	151	0	0	2	5310
WP3303	Rac1/Pak1/p38/MMP-2 pathway	1.00000000001999	1.99907660412314e-11	68	0	0	2	5310
WP45	G1 to S cell cycle control	1.00000000001999	1.99907660412314e-11	68	0	0	2	5310
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	1.00000000001999	1.99907660412314e-11	68	0	0	2	5310
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	1.00000000001999	1.99907660412314e-11	68	0	0	2	5310
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	1.00000000001999	1.99907660412314e-11	68	0	0	2	5310
WP2513	Nanoparticle triggered regulated necrosis	1.00000000002442	2.44245917063832e-11	11	0	0	2	5310
WP1455	Serotonin Transporter Activity	1.00000000002442	2.44245917063832e-11	11	0	0	2	5310
WP80	Nucleotide GPCRs	1.00000000002442	2.44245917063832e-11	11	0	0	2	5310
WP3630	NAD metabolism, sirtuins and aging	1.00000000002442	2.44245917063832e-11	11	0	0	2	5310
WP2854	Gene regulatory network modelling somitogenesis	1.00000000002442	2.44245917063832e-11	11	0	0	2	5310
